INTRAVITREAL BEVACIZUMAB FOR TREATMENT OF PROLIFERATIVE AND NONPROLIFERATIVE TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA

Overview of attention for article published in Retina, October 2011

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (65th percentile)
Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

twitter: 1 X user

patent: 5 patents

Readers on

mendeley: 36 Mendeley

So far, Altmetric has seen 1 X post from an account with 363 followers.

[VEGF] Intravitreal bevacizumab for treatment of proliferative and nonproliferative type 2 idiopathic macular... http://t.co/kHeESCXZ PM

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.

Login to access the Sentiment Analysis related to this output.